You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

PREMPRO Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PREMPRO?
  • What are the global sales for PREMPRO?
  • What is Average Wholesale Price for PREMPRO?
Summary for PREMPRO
Drug patent expirations by year for PREMPRO
Drug Prices for PREMPRO

See drug prices for PREMPRO

Drug Sales Revenue Trends for PREMPRO

See drug sales revenues for PREMPRO

Recent Clinical Trials for PREMPRO

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PfizerPhase 3
MDS Pharma ServicesPhase 1
BayerPhase 2

See all PREMPRO clinical trials

Pharmacology for PREMPRO
Drug ClassEstrogen
Progestin
Mechanism of ActionEstrogen Receptor Agonists

US Patents and Regulatory Information for PREMPRO

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Pharms PREMPRO estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-005 Jun 4, 2003 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms PREMPRO estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-003 Jan 9, 1998 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms PREMPRO estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-004 Mar 12, 2003 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms PREMPRO estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-001 Nov 17, 1995 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PREMPRO

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Pharms PREMPRO estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-003 Jan 9, 1998 ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms PREMPRO estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-003 Jan 9, 1998 ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms PREMPRO estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-005 Jun 4, 2003 ⤷  Sign Up ⤷  Sign Up
Wyeth Pharms PREMPRO estrogens, conjugated; medroxyprogesterone acetate TABLET;ORAL-28 020527-004 Mar 12, 2003 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PREMPRO

See the table below for patents covering PREMPRO around the world.

Country Patent Number Title Estimated Expiration
Finland 117592 ⤷  Sign Up
Mexico 9700515 LIBERACION CONTROLADA DE ESTEROIDES A PARTIR DE REVESTIMIENTOS DE AZUCAR. (CONTROLLED RELEASE OF STEROIDS FROM SUGAR COATINGS.) ⤷  Sign Up
Turkey 9700052 ⤷  Sign Up
Hungary T67553 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for PREMPRO

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0136011 97C0056 Belgium ⤷  Sign Up PRODUCT NAME: OESTROGENES CONJUGUES + MEDROXYPROGESTERONACETAS; NAT. REGISTRATION NO/DATE: 428 IS 194 F 3 19970520; FIRST REGISTRATION: CH 52649 19940826
0136011 2000C/027 Belgium ⤷  Sign Up PRODUCT NAME: ETHINYLESTRADIOLUM / NORETHISTERONI ACETAS; NAT. REGISTRATION NO/DATE: 19 IS 106 F3 20000911; FIRST REGISTRATION: NL RVG 23909 19991124
0136011 SPC/GB00/028 United Kingdom ⤷  Sign Up SPC/GB00/028: 20040802, EXPIRES: 20090801
0136011 980038 Netherlands ⤷  Sign Up 980038, 20090801, EXPIRES: 20130305
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.